Universite Paris 12 - Val De Marne;Centre National de la Recherche Scientifique (CNRS);Elro Pharma
发明人:
Zimmer, Robert,Courty, Jose
申请号：
AU2011311665
公开号：
AU2011311665A1
申请日:
2011.10.04
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
The present invention relates to a composition comprising a Nucant multivalent synthetic compound and a glycosaminoglycan, the admixture of both compounds forming microspheres comprising both compounds, as well as their use for the treatment or prevention of diseases associated to deregulation of proliferation and/or angiogenesis, such as cancer, inflammatory disease, or for promoting wound healing
